TLPH Talphera Inc.

  1. Stocks
  2. Healthcare
  3. NASDAQ: TLPH

Price (delayed)

$0.85

Market cap

$14.44M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.85

Enterprise value

$8.64M

acelrx pharmaceuticals inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. the company’s product candidates, dsuvia™ (known ...

Highlights
The quick ratio has surged by 167% since the previous quarter
TLPH's equity is up by 16% from the previous quarter and by 15% YoY
TLPH's net income has plunged by 129% YoY but it is up by 23% from the previous quarter
TLPH's EPS has dropped by 114% year-on-year but it is up by 34% since the previous quarter
Talphera's debt has soared by 87% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.acelrx.com

Key stats

What are the main financial stats of TLPH
Market
Shares outstanding
16.99M
Market cap
$14.44M
Enterprise value
$8.64M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.88
Price to sales (P/S)
32.28
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
13.27
Earnings
Revenue
$651,000
EBIT
-$13.74M
EBITDA
-$13.69M
Free cash flow
-$15.13M
Per share
EPS
-$0.85
Free cash flow per share
-$0.61
Book value per share
$0.96
Revenue per share
$0.03
TBVPS
$1.16
Balance sheet
Total assets
$28.77M
Total liabilities
$12.44M
Debt
$6.31M
Equity
$16.33M
Working capital
$16.61M
Liquidity
Debt to equity
0.39
Current ratio
5.97
Quick ratio
5.56
Net debt/EBITDA
0.42
Margins
EBITDA margin
-2,103.5%
Gross margin
100%
Net margin
-2,181.1%
Operating margin
-2,426.7%
Efficiency
Return on assets
-63%
Return on equity
-96%
Return on invested capital
-130.3%
Return on capital employed
-54%
Return on sales
-2,111.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TLPH stock price

How has the Talphera stock price performed over time
Intraday
1.19%
1 week
-1.16%
1 month
2.41%
1 year
-16.67%
YTD
15.65%
QTD
-4.49%

Financial performance

How have Talphera's revenue and profit performed over time
Revenue
$651,000
Gross profit
$651,000
Operating income
-$15.8M
Net income
-$14.2M
Gross margin
100%
Net margin
-2,181.1%
TLPH's net income has plunged by 129% YoY but it is up by 23% from the previous quarter
Talphera's operating income has increased by 39% YoY and by 6% QoQ
Talphera's net margin has increased by 23% from the previous quarter
TLPH's operating margin is up by 6% QoQ

Growth

What is Talphera's growth rate over time

Valuation

What is Talphera stock price valuation
P/E
N/A
P/B
0.88
P/S
32.28
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
13.27
TLPH's EPS has dropped by 114% year-on-year but it is up by 34% since the previous quarter
TLPH's equity is up by 16% from the previous quarter and by 15% YoY
The P/B is 2.2% more than the last 4 quarters average of 0.9
TLPH's price to sales (P/S) is 96% lower than its 5-year quarterly average of 940.1 but 3.5% higher than its last 4 quarters average of 32.4

Efficiency

How efficient is Talphera business performance
TLPH's ROA has dropped by 168% year-on-year but it is up by 25% since the previous quarter
The company's return on invested capital has shrunk by 157% YoY but it rose by 48% QoQ
The company's return on equity has shrunk by 156% YoY but it rose by 26% QoQ
TLPH's return on sales is up by 25% since the previous quarter

Dividends

What is TLPH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TLPH.

Financial health

How did Talphera financials performed over time
Talphera's total assets is 131% higher than its total liabilities
The quick ratio has surged by 167% since the previous quarter
The company's current ratio has surged by 132% QoQ
Talphera's debt is 61% less than its equity
Talphera's debt has soared by 87% YoY
The debt to equity has soared by 63% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.